abstract |
The present invention relates to an antibody that specifically binds to epidermal growth factor receptor variant III (EGFRvIII), a nucleic acid encoding the antibody, a vector comprising the nucleic acid, a host cell, a method for producing the antibody, And to a pharmaceutical composition for treating cancer or tumor. |